Skip to content
Screener

Praxis Precision Medicines, Inc. PRAX Total Current Liabilities

Total Current Liabilities at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$2.25B+83.8%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$45.01M+36.2%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$40.81M-8.7%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$28.42M+139%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$1.01M
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$831.7M+59.1%

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:32 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001689548-26-000083
Line itemJune 30, 2026December 31, 2025
Accounts payable$23,386$24,628
Accrued expenses24,58535,033
Operating lease liabilities1,087110
Total current liabilities49,05859,771
Total liabilities49,05859,771
Commitments and contingencies (Note 6)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of June 30, 2026 and December 31, 2025

Item 1. Financial Statements (Unaudited)

FAQ

What is Praxis Precision Medicines, Inc.'s total current liabilities?
Praxis Precision Medicines, Inc. (PRAX) reported total current liabilities of $49.06M in Q2 2026.
How has Praxis Precision Medicines, Inc.'s total current liabilities changed year-over-year?
Praxis Precision Medicines, Inc.'s total current liabilities increased by 0.9% year-over-year, from $48.61M to $49.06M.
What is the long-term trend for Praxis Precision Medicines, Inc.'s total current liabilities?
Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total current liabilities has grown at a 30.6% compound annual growth rate (CAGR), from $15.72M to $59.77M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Praxis Precision Medicines, Inc.'s total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude